Does Dr. CARL LANDGREN have financial conflicts of interest?

Dr. CARL LANDGREN (MD) has received a total of $397,209 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $390,075 in personal promotional payouts (consulting, meals, travel) and $7,133 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CARL LANDGREN?

According to CMS Open Payments data, Dr. CARL LANDGREN received funding from AMGEN ($107,011), PFIZER ($45,763), and GENZYME CORPORATION ($40,804).

Does Dr. CARL LANDGREN receive research grants or speaking fees?

Dr. CARL LANDGREN has received $390,075 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $7,133 in clinical research grants.

DR. CARL LANDGREN

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: MIAMI, FL 33136

NPI Number: 1972926871

LIFETIME INDUSTRY VALUE

$397,209

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. LANDGREN is a verified Internal Medicine, Hematology & Oncology practitioner based in MIAMI, FL.

Between 2021 and 2025, Dr. LANDGREN had an overall industry promotional and research financial footprint of $397,209 as recorded in the federal CMS Open Payments database.

$390,075 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$7,133 was allocated to sponsored clinical trials and medical research activities.

Dr. LANDGREN's primary funding source is AMGEN, which accounts for $107,011 (representing 26.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

AMGEN

Rank 1

$107,011

26.9%

PFIZER

Rank 2

$45,763

11.5%

GENZYME CORPORATION

Rank 3

$40,804

10.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.